Status:
COMPLETED
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
Lead Sponsor:
National Allergy Research Center, Denmark
Conditions:
Granuloma
Aluminum Allergy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Vaccines and subcutanoeus immunotherapy vaccines often contains aluminium, and may induce itching granulomas at the injection site. This is usually diagnosed by patch testing. Another way of detecting...
Detailed Description
Aluminium-adsorbed vaccines and subcutaneous immunotherapy may induce vaccination granulomas at injection site. Most children have concormitant aluminium contact allergy diagnosed by path testing, but...
Eligibility Criteria
Inclusion
- Indivicuals with vaccination granulomas
- controls without granulomas and no suspected contact allergies
Exclusion
- pregnancy, breastfeeding, recent vaccination, skin diseases
Key Trial Info
Start Date :
September 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06130462
Start Date
September 13 2022
End Date
February 20 2023
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Allergy Research Centre, Gentofte Hospital
Hellerup, Denmark, 2900